Form 4 Tracker
Acumen Pharmaceuticals, Inc.
ABOS

26 insider filings · Latest: Jun 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 5, 2026Jan 5 10:06 PMBarton Russell
Proposed Sale
4,000$1.96$7.8K

View →

Jan 5, 2026Jan 5 10:03 PMZuga Matt
Proposed Sale
4,000$1.96$7.8K

View →

Jan 5, 2026Jan 5 9:48 PMOConnell Daniel Joseph
Proposed Sale
4,649$1.97$9.2K

View →

Jan 23, 2025Jan 23 9:17 PMZuga Matt
Proposed Sale
28,902$1.72$49.6K

View →

Jan 21, 2025Jan 21 9:32 PMMeisner Derek M
Proposed Sale
3,418$1.59$5.4K

View →

Jan 21, 2025Jan 21 9:31 PMSiemers Eric
Proposed Sale
3,219$1.59$5.1K

View →

Jan 21, 2025Jan 21 9:29 PMBarton Russell
Proposed Sale
2,914$1.70$5.0K

View →

Jan 21, 2025Jan 21 9:25 PMZuga Matt
Proposed Sale
4,364$1.60$7.0K

View →

Jan 21, 2025Jan 21 9:24 PMOConnell Daniel Joseph
Proposed Sale
12,619$1.59$20.1K

View →

Jan 3, 2025Jan 3 11:16 PMMeisner Derek M
Proposed Sale
11,122$1.84$20.5K

View →

Jan 3, 2025Jan 3 11:04 PMSiemers Eric
Proposed Sale
10,859$1.85$20.0K

View →

Jan 3, 2025Jan 3 10:59 PMBarton Russell
Proposed Sale
7,636$1.86$14.2K

View →

Jan 3, 2025Jan 3 10:54 PMZuga Matt
Proposed Sale
13,235$1.84$24.4K

View →

Jan 3, 2025Jan 3 10:00 PMOConnell Daniel Joseph
Proposed Sale
47,778$1.84$87.9K

View →

← Previous

Page 4 of 4

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 16, 2026Jan 21 11:29 PMJames J. DohertyPresident and CDO
Grant/Award
250,300$1.89250,300(D)

View →

← Previous

Page 2 of 2